REPARRIS Trademark

Trademark Overview


On Thursday, August 24, 2023, a trademark application was filed for REPARRIS with the United States Patent and Trademark Office. The USPTO has given the REPARRIS trademark a serial number of 98149199. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 10, 2024. This trademark is owned by ReParris, Inc.. The REPARRIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for regenerative medicine, namely, pharmaceutical preparations for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, and ocular disorders and diseases, eye diseases and conditions, respiratory, neurological, gastrointestinal, hormonal, dermatological, and skin damage and disorders, tissue damage and disorders, soft tissue wounds, immune system related diseases and disorders, central and peripheral nervous system, tendon and muscle injuries and disorders, and cell rejuvenation; Pharmaceutical preparations for treating pain, arthritis, fibrosis, orthopedic disorders, inflammatory disorders and musculoskeletal disorders; Veterinary pharmaceutical preparations for the treatment and prevention of diseases and conditions, namely, for treating pain, arthritis, fibrosis, orthopedic disorders, inflammatory disorders and musculoskeletal disord...
reparris

General Information


Serial Number98149199
Word MarkREPARRIS
Filing DateThursday, August 24, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, September 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 16, 2024

Trademark Statements


Goods and ServicesPharmaceutical products for regenerative medicine, namely, pharmaceutical preparations for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, and ocular disorders and diseases, eye diseases and conditions, respiratory, neurological, gastrointestinal, hormonal, dermatological, and skin damage and disorders, tissue damage and disorders, soft tissue wounds, immune system related diseases and disorders, central and peripheral nervous system, tendon and muscle injuries and disorders, and cell rejuvenation; Pharmaceutical preparations for treating pain, arthritis, fibrosis, orthopedic disorders, inflammatory disorders and musculoskeletal disorders; Veterinary pharmaceutical preparations for the treatment and prevention of diseases and conditions, namely, for treating pain, arthritis, fibrosis, orthopedic disorders, inflammatory disorders and musculoskeletal disorders, bacterial infections, gastrointestinal infections, intestinal parasitic infections, wounds, damaged skin and tissue, and heartworm disease; Veterinary pharmaceutical preparations for the treatment of pain and inflammation; Vitamins; nutritional supplements; dietary supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 25, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameReParris, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLancaster, CA 93534

Party NameReParris, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLancaster, CA 93534

Trademark Events


Event DateEvent Description
Monday, August 28, 2023NEW APPLICATION ENTERED
Monday, September 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 24, 2024ASSIGNED TO EXAMINER
Wednesday, April 24, 2024NON-FINAL ACTION E-MAILED
Wednesday, April 24, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 24, 2024NON-FINAL ACTION WRITTEN
Friday, June 7, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 7, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 10, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 26, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED